Search

Your search keyword '"Ashraf Z"' showing total 935 results

Search Constraints

Start Over You searched for: Author "Ashraf Z" Remove constraint Author: "Ashraf Z"
935 results on '"Ashraf Z"'

Search Results

301. Transient behavior of heavy metals in soils during electrokinetic remediation

302. Epidemiology and outcome of rifampicin resistant tuberculosis in Upper Egypt

303. Exploring the Effect of Cognitive – Behavioral Counseling on Marital Satisfaction and Quality of Life Through Virtual Education

304. Geochemical assessment of metal transport in glacial till during electrokinetic remediation

305. Comparison of imaging with FDG PET/CT with other imaging modalities in myeloma

306. تمهيد الارضية لظهور الإمام القائم () بناءاً علي أسباب ظهوره في الروايات

307. Anthracycline versus Non-anthracycline Induction Regimens in Patients with De Novo Acute Myeloid Leukemia.

308. Side-by-Side Evaluation of Stormwater Proprietary BMPs

309. Case 38-2004: a large tumor of the skull

310. Impact of Prior Therapies on the Safety and Efficacy of Once Weekly Selinexor, Bortezomib, and Dexamethasone Compared with Twice Weekly Bortezomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma: Results from the Boston Study

311. Effect of Prior Treatment with Proteasome Inhibitors on the Efficacy and Safety of Once-Weekly Selinexor, Bortezomib, and Dexamethasone in Comparison with Twice-Weekly Bortezomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma: Subgroup Analysis from the Boston Study

312. Vasoactive mediators (VEGF and TNF-alpha) in patients with malignant and tuberculous pleural effusions

313. Tonsillectomy blood splash

315. A Pilot Study of Acupuncture in Treating Bortezomib-Induced Peripheral Neuropathy in Patients With Multiple Myeloma

319. Activated protein C resistance in the absence of factor V Leiden mutation is a common finding in multiple myeloma and is associated with an increased risk of thrombotic complications

320. Bioinformatics Prediction of miRNAs Targeting E6 and E7 Genes in Human Papillomavirus Types 16 and 18 in Cervical Cancer

321. Inhibition of indole production increases the activity of quinolone antibiotics against E. coli persisters

322. Characteristics and outcomes of mitral valve repair surgery: a single-center experience

323. Clinical activity of arsenic trioxide for the treatment of multiple myeloma

324. A535 Phase II Trial of Bortezomib and Rituximab in Relapsed/Refractory Waldenström Macroglobulinemia

325. Structural and functional consequences of alveolar cell recognition by CD8(+) T lymphocytes in experimental lung disease

327. Adoptive immunotherapy with engineered T cells expressing and HLA-A2 restricted affinity-enhanced TCR for LAGE-1 and NY-ESO-1 in patients with multiple myeloma following auto-SCT

328. Abstract 4575: Correlates of clinical response following autologous stem cell transplant and adoptive immunotherapy with engineered T cells expressing an affinity-enhanced T cell receptor in patients with mutliple myeloma.

329. A Review of Groundwater Contamination in West Bank, Palestine: Quality, Sources, Risks, and Management

330. Lignocellulosic Biomasses from Agricultural Wastes Improved the Quality and Physicochemical Properties of Frying Oils

332. Abstract 4575: Correlates of clinical response following autologous stem cell transplant and adoptive immunotherapy with engineered T cells expressing an affinity-enhanced T cell receptor in patients with mutliple myeloma

334. Combination Immunotherapy After ASCT for Multiple Myeloma (MM) Using MAGE-A3/Poly-ICLC Immunizations Followed by Vaccine-Primed and Activated Autologous T-Cells

335. Adoptive Transfer of Gene-Modified T-Cells Engineered to Express High-Affinity TCRs for Cancer-Testis Antigens (CTAs) NY-ESO-1 or Lage-1, in MM Patients Post Auto-SCT

336. Prolonged T Cell Persistence, Homing to Marrow and Selective Targeting of Antigen Positive Tumor in Multiple Myeloma Patients Following Adoptive Transfer of T Cells Genetically Engineered to Express an Affinity-Enhanced T Cell Receptor Against the Cancer Testis Antigens NY-ESO-1 and Lage-1

337. A Pilot Study of Acupuncture in Treating Bortezomib-Induced Peripheral Neuropathy (BIPN) in Multiple Myeloma (MM) Patients.

345. Charlie Teo Foundation Brain Tumour Bank

346. Persister Escherichia coli Cells Have a Lower Intracellular pH than Susceptible Cells but Maintain Their pH in Response to Antibiotic Treatment

347. Investigation of the structure and compressive strength of a bioceramic root canal sealer reinforced with nanomaterials

348. A Phase II Trial of Bortezomib and Vorinostat in Mantle Cell Lymphoma and Diffuse Large B-Cell Lymphoma

349. A Phase II Study of the MEK 1/2 Inhibitor AZD6244 (Selumetinib, ARRY-142866) in Relapsed or Refractory Multiple Myeloma

350. Integrated Safety From Phase 2 Studies of Monotherapy Carfilzomib in Patients with Relapsed and Refractory Multiple Myeloma (MM): An Updated Analysis

Catalog

Books, media, physical & digital resources